• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于经动脉化疗栓塞的载阿霉素药物洗脱微球(DC Bead®):稳定性评估

Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: a stability assessment.

作者信息

Hecq Jean-Daniel, Lewis Andrew L, Vanbeckbergen Danielle, Athanosopoulos Alexandre, Galanti Laurence, Jamart Jacques, Czuczman Peter, Chung Ting

机构信息

Pharmacy Department, CHU Mont-Godinne, Yvoir & Drug Stability Research Group, Brussels, Belgium.

出版信息

J Oncol Pharm Pract. 2013 Mar;19(1):65-74. doi: 10.1177/1078155212452765. Epub 2012 Jul 16.

DOI:10.1177/1078155212452765
PMID:22801955
Abstract

PURPOSE

Evaluation of doxorubicin stability over time when stored into the DC Bead embolic agent, in various containers, which are used for the delivery of the doxorubicin-loaded beads to the patients for up to 14 days under refrigerated conditions.

METHODS

The doxorubicin was loaded through the ionic exchange mechanism into the calibrated polyvinyl alcohol-based hydrogel beads (DC Bead), with the loading process carried out either in the original DC Bead glass vials or within a polypropylene plastic syringe. The loaded samples were eluted at given time points and the extracted doxorubicin was analysed by high-performance liquid chromatography for concentration and chromatographic area response purity.

RESULTS

The variance on the doxorubicin concentration of the samples stored in the syringes under refrigerated conditions was less than 10% over the 14 days period. The chromatographic purity of doxorubicin eluted from the DC Bead in their primary glass vial packaging was measured at 99.7%. The dissolution test showed that the elution rate and amount recovered from samples stored in vials were statistically similar between Day 0 and Day 14. The chromatographic purity of the doxorubicin loaded into DC Bead in presence of non-ionic contrast medium was >99.0% for 7 days under refrigerated conditions.

CONCLUSIONS

Doxorubicin-loaded DC Bead® are shown to have adequate physicochemical stability over a period of 14 days when stored in syringes or vials under refrigerated conditions for up to 14 days. The admixtures of doxorubicin-loaded beads with contrast medium are stable for up to 7 days under refrigerated conditions.

摘要

目的

评估阿霉素在储存于DC Bead栓塞剂中时,在不同容器内随时间的稳定性。这些容器用于将载有阿霉素的微球输送给患者,并在冷藏条件下保存长达14天。

方法

通过离子交换机制将阿霉素加载到校准的聚乙烯醇基水凝胶微球(DC Bead)中,加载过程在原始的DC Bead玻璃瓶或聚丙烯塑料注射器中进行。在给定时间点对加载后的样品进行洗脱,并通过高效液相色谱法分析提取的阿霉素的浓度和色谱面积响应纯度。

结果

在冷藏条件下储存在注射器中的样品,其阿霉素浓度在14天内的变化小于10%。从DC Bead的原始玻璃瓶包装中洗脱的阿霉素的色谱纯度经测定为99.7%。溶出试验表明,在第0天和第14天之间,从小瓶中储存的样品中回收的洗脱速率和量在统计学上相似。在非离子型造影剂存在的情况下,加载到DC Bead中的阿霉素在冷藏条件下7天内的色谱纯度>99.0%。

结论

当在冷藏条件下储存在注射器或小瓶中长达14天时,载有阿霉素的DC Bead®显示在14天内具有足够的物理化学稳定性。载有阿霉素的微球与造影剂的混合物在冷藏条件下长达7天是稳定的。

相似文献

1
Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: a stability assessment.用于经动脉化疗栓塞的载阿霉素药物洗脱微球(DC Bead®):稳定性评估
J Oncol Pharm Pract. 2013 Mar;19(1):65-74. doi: 10.1177/1078155212452765. Epub 2012 Jul 16.
2
Stability of irinotecan-loaded drug eluting beads (DC Bead) used for transarterial chemoembolization.用于经动脉化疗栓塞的载伊立替康药物洗脱微球(DC微球)的稳定性
J Oncol Pharm Pract. 2010 Mar;16(1):53-61. doi: 10.1177/1078155209337650. Epub 2009 Jul 17.
3
DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization.DC微球:经动脉化疗栓塞给药装置的体外特性研究
J Vasc Interv Radiol. 2006 Feb;17(2 Pt 1):335-42. doi: 10.1097/01.RVI.0000195323.46152.B3.
4
Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media.载表柔比星DC微球™与不同非离子型造影剂的相容性。
J Oncol Pharm Pract. 2016 Dec;22(6):749-756. doi: 10.1177/1078155215607088. Epub 2015 Oct 1.
5
Loading, release and stability of epirubicin-loaded drug-eluting beads.表柔比星载药洗脱微球的负载、释放及稳定性
J Oncol Pharm Pract. 2016 Aug;22(4):591-8. doi: 10.1177/1078155215594416. Epub 2015 Jul 8.
6
An In Vitro Evaluation of Four Types of Drug-Eluting Microspheres Loaded with Doxorubicin.四种载有多柔比星的药物洗脱微球的体外评价
J Vasc Interv Radiol. 2016 Sep;27(9):1425-1431. doi: 10.1016/j.jvir.2016.05.015. Epub 2016 Jul 9.
7
Loading profile of topotecan into polyvinyl alcohol microspheres (DC Bead™) over a 7-day period.在7天时间内,拓扑替康载入聚乙烯醇微球(DC Bead™)的情况。
J Oncol Pharm Pract. 2012 Jun;18(2):222-8. doi: 10.1177/1078155211426197. Epub 2011 Nov 10.
8
Elution characteristics of doxorubicin-loaded microspheres differ by drug-loading method and microsphere size.载多柔比星微球的洗脱特性因药物加载方法和微球粒径而异。
J Vasc Interv Radiol. 2011 Mar;22(3):361-8. doi: 10.1016/j.jvir.2010.11.032.
9
Spatiotemporal dynamics of doxorubicin elution from embolic beads within a microfluidic network.载药微球在微流控网络中药物洗脱的时空动力学
J Control Release. 2015 Sep 28;214:62-75. doi: 10.1016/j.jconrel.2015.07.003. Epub 2015 Jul 6.
10
New insights into the mechanisms of the interactions between doxorubicin and the ion-exchange hydrogel DC Bead™ for use in transarterial chemoembolization (TACE).多柔比星与用于经动脉化疗栓塞术 (TACE) 的离子交换水凝胶 DC Bead™ 相互作用机制的新见解。
J Biomater Sci Polym Ed. 2012;23(1-4):333-54. doi: 10.1163/092050610X551934. Epub 2011 Jan 21.

引用本文的文献

1
Systematic review of transarterial chemoembolization for desmoid tumors: a promising locoregional treatment for challenging tumor.硬纤维瘤经动脉化疗栓塞术的系统评价:一种针对具有挑战性肿瘤的有前景的局部治疗方法。
Discov Oncol. 2025 Jul 1;16(1):1193. doi: 10.1007/s12672-025-03007-y.
2
Microspheres as a Carrier System for Therapeutic Embolization Procedures: Achievements and Advances.作为治疗性栓塞程序载体系统的微球:成就与进展
J Clin Med. 2023 Jan 24;12(3):918. doi: 10.3390/jcm12030918.
3
Selective Intra-Arterial Doxorubicin Eluting Microsphere Embolization for Desmoid Fibromatosis: A Combined Prospective and Retrospective Study.
选择性动脉内阿霉素洗脱微球栓塞治疗硬纤维瘤病:一项前瞻性与回顾性相结合的研究
Cancers (Basel). 2022 Oct 14;14(20):5045. doi: 10.3390/cancers14205045.
4
MicroRNAs Related to TACE Treatment Response: A Review of the Literature from a Radiological Point of View.与TACE治疗反应相关的微小RNA:从放射学角度对文献的综述
Diagnostics (Basel). 2022 Feb 1;12(2):374. doi: 10.3390/diagnostics12020374.
5
The opacity of mineral ion-loaded bead (DC beads) on low-keV monochromatic images from dual energy CT and T1-weighted gradient-echo MRI.矿物离子负载珠(DC 珠)在双能 CT 低 keV 单色图像和 T1 加权梯度回波 MRI 上的不透明度。
Jpn J Radiol. 2019 Sep;37(9):660-665. doi: 10.1007/s11604-019-00856-w. Epub 2019 Jul 23.
6
Compatibility of irinotecan-loaded DC Bead with different volumes and types of non-ionic contrast media.载伊立替康的DC微球与不同体积和类型的非离子型造影剂的相容性。
Eur J Hosp Pharm. 2016 Jan;23(1):38-43. doi: 10.1136/ejhpharm-2015-000668. Epub 2015 Aug 11.
7
3D Printed Absorber for Capturing Chemotherapy Drugs before They Spread through the Body.用于在化疗药物扩散至全身之前进行捕获的3D打印吸收器。
ACS Cent Sci. 2019 Mar 27;5(3):419-427. doi: 10.1021/acscentsci.8b00700. Epub 2019 Jan 9.
8
CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.与传统经动脉化疗栓塞术相比,载药微球经导管动脉化疗栓塞术治疗肝细胞癌患者疗效更佳且安全性相当。
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819830751. doi: 10.1177/1533033819830751.
9
Chemoembolization with DC Bead™ for the treatment of hepatocellular carcinoma: an update.使用DC Bead™进行化疗栓塞治疗肝细胞癌:最新进展
Hepat Oncol. 2014 Apr;1(2):205-214. doi: 10.2217/hep.13.18. Epub 2014 Mar 20.
10
Chemoembolization With Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma.载药微球化疗栓塞术治疗肝细胞癌
J Adv Pract Oncol. 2016 Nov-Dec;7(7):764-778. doi: 10.6004/jadpro.2016.7.7.8. Epub 2016 Nov 1.